Results 31 to 40 of about 101,265 (243)
Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
Antibiotics, 2021 Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-
Jan C. Kamp +8 more
doaj +1 more source
Measures to eradicate multidrug-resistant organism outbreaks: How much does it cost? [PDF]
, 2015 This study aimed to assess the economic burden of infection control measures that succeeded in eradicating multidrug-resistant organisms (MDROs) in emerging epidemic contexts in hospital settings.
Birgand, GJC +6 more
core +1 more source
Microorganisms, 2021 Acinetobacter baumannii is a Gram-negative coccobacillus responsible for severe hospital-acquired infections, particularly in intensive care units (ICUs).
Mahmoud A. F. Khalil +12 more
doaj +1 more source
Open conversion after aortic endograft infection. Caused by colistin-resistant, carbapenemase-producing Klebsiella pneumoniae [PDF]
, 2016 A 62-year-old man presented with fever, abdominal pain, and malaise 13 months after emergency endovascular aortic repair. Computed tomographic angiograms showed a periprosthetic fluid and gas collection, so infection was diagnosed. Open conversion was
Capoccia, Laura +5 more
core +1 more source
Bezmiâlem Science, 2019 Objective:Resistant Gram-negative bacteria isolated from health-related infections are a worldwide problem. Increasing frequency of infections particularly caused by Enterobacteriaceae producing expanded spectrum beta lactamase, leads to the use of more ...
Mustafa SAMASTI +4 more
doaj +1 more source
Pathogens, 2022 Considering the growing prevalence of carbapenem-resistant Gram-negative bacteria (CR-GNB) bloodstream infection (BSI) in intensive care units (ICUs), the identification of specific risk factors and the development of a predictive model allowing for the ...
Giorgia Montrucchio +10 more
doaj +1 more source
Carbapenem resistance in Canada [PDF]
Canadian Medical Association Journal, 2009 For more than 2 decades, carbapenems have been considered the pharmacotherapy of last resort for managing multidrug-resistant infections caused by Enterobacteriaceae bacteria (e.g., Escherichia coli and Salmonella ).
Baldwin, Toye +4 more
openaire +2 more sources
Frontiers in Microbiology, 2017 The worldwide dissemination of carbapenemase-producing Enterobacteriaceae (CPE) has become a major therapeutic concern in clinical settings. Enterobacter cloacae is a major pathogen that causes serious hospital-acquired infections.
Jong Ho Lee +3 more
doaj +1 more source
Journal of Antimicrobial Chemotherapy, 2020 AbstractBackgroundThe dissemination of MBLs compromises effective use of many β-lactams in the treatment of patients with life-threatening bacterial infections. Predicted global increases in the prevalence of MBL-producing carbapenem-resistant Enterobacterales (CRE) are being realized, yielding infections that are untreatable with existing therapies ...
Nicola Ooi +8 more
openaire +3 more sources
Frontiers in Veterinary Science, 2021 Septic synovitis is a critical orthopedic condition in horses. Early intervention is key, with antibiotic therapy typically initiated prior to culture and susceptibility reports becoming available.
Allison P. Mosichuk +5 more
doaj +1 more source